Clinical Decision Support Cds For Chronic Care Market
Clinical Decision Support (CDS) for Chronic Care Market Forecasts to 2032 – Global Analysis By Component (Software, Services and Other Components), Product (Standalone CDS Systems, Mobile-Based CDS Tools, Integrated CDS with EHR, AI-Driven CDS Platforms and Other Products), Therapeutic Area, Application, End User and By Geography
According to Stratistics MRC, the Global Clinical Decision Support (CDS) for Chronic Care Market is accounted for $0.9 billion in 2025 and is expected to reach $2.2 billion by 2032 growing at a CAGR of 12.5% during the forecast period. Clinical Decision Support (CDS) for Chronic Care is to intelligent health IT systems that deliver patient-specific insights to aid clinicians in managing long-term conditions. These tools integrate evidence-based guidelines, real-time data, and predictive analytics to optimize diagnosis, treatment planning, and monitoring. CDS enhances care quality by identifying risks, suggesting interventions, and streamlining workflows. In chronic disease management, it supports continuity, reduces errors, and promotes timely, personalized care decisions aligned with clinical protocols and patient history
Market Dynamics:
Driver:
Growing adoption of electronic health records (EHRs) and digital health
Integration of CDS with EHR platforms enables real-time clinical insights, streamlining decision-making for physicians and improving patient outcomes. Digital health innovations, including mobile apps and cloud-based analytics, are enhancing the accessibility and scalability of CDS solutions. These technologies support longitudinal tracking of chronic conditions, enabling proactive interventions. Moreover, interoperability standards are evolving to facilitate seamless data exchange across care settings, further boosting CDS utility.
Restraint:
Alert fatigue and usability issues
Despite their clinical value, CDS systems often generate excessive alerts, leading to desensitization among healthcare providers. This phenomenon, known as alert fatigue, can result in critical warnings being overlooked, compromising patient safety. Additionally, poorly designed user interface and complex workflows hinder system adoption, especially in high-volume clinical environments. Customization challenges and lack of intuitive navigation reduce operational efficiency.
Opportunity:
Patient-centered and shared decision-making tools
Tools that facilitate shared decision-making—such as risk calculators, treatment comparison dashboards, and preference-sensitive algorithms—are gaining traction. These systems enhance transparency and foster collaborative discussions between patients and providers. As chronic conditions often require long-term management, engaging patients in treatment planning improves adherence and satisfaction. The growing emphasis on value-based care is further encouraging the integration of patient-centric functionalities into CDS frameworks.
Threat:
Lack of user adoption and acceptance
Concerns about clinical autonomy, data reliability, and workflow disruption contribute to low adoption rates. Additionally, insufficient training and lack of institutional support can hinder effective implementation. In some cases, CDS tools are perceived as burdensome rather than beneficial, especially when they fail to align with existing clinical practices. Overcoming these barriers requires targeted education, stakeholder engagement, and evidence-based validation of CDS efficacy.
Covid-19 Impact:
The pandemic accelerated digital transformation in healthcare, indirectly benefiting the CDS market for chronic care. With in-person consultations limited, providers increasingly relied on remote monitoring and virtual decision support tools to manage chronic conditions. CDS systems played a crucial role in triaging patients, optimizing medication regimens, and identifying high-risk individuals. However, initial disruptions in IT infrastructure and resource allocation delayed some deployments.
The standalone CDS systems segment is expected to be the largest during the forecast period
The standalone CDS systems segment is expected to account for the largest market share during the forecast period due to their flexibility and compatibility with diverse healthcare environments. These systems operate independently of EHRs, allowing integration with various data sources and third-party applications. Their modular architecture supports tailored functionalities for chronic disease management, including predictive analytics and evidence-based guidelines. The segment benefits from growing demand in outpatient settings, where standalone tools offer cost-effective and scalable solutions.
The diabetes & chronic disease management segment is expected to have the highest CAGR during the forecast period
Over the forecast period, the diabetes & chronic disease management segment is predicted to witness the highest growth rate driven by rising global disease burden and demand for continuous care solutions. CDS tools in this domain offer personalized treatment recommendations, medication tracking, and lifestyle interventions. Integration with wearable devices and mobile health apps enables real-time data capture, supporting dynamic decision-making. The segment is also benefiting from government initiatives promoting digital therapeutics and chronic care coordination.
Region with largest share:
During the forecast period, the Asia Pacific region is expected to hold the largest market share attributed to expanding healthcare infrastructure and rising chronic disease prevalence. Countries like China, India, and Japan are investing heavily in digital health ecosystems, including CDS integration with national EHR programs. The region’s large patient population and increasing adoption of telemedicine are driving demand for scalable decision support tools. Regulatory reforms and public-private partnerships are further catalyzing market growth.
Region with highest CAGR:
Over the forecast period, the North America region is anticipated to exhibit the highest CAGR fueled by advanced healthcare digitization and strong policy support for clinical innovation. The region boasts a mature EHR landscape, facilitating seamless CDS deployment across hospitals and clinics. Ongoing research in AI and machine learning is enhancing the sophistication of CDS algorithms, particularly for chronic disease prediction and management. Reimbursement models favoring value-based care are incentivizing providers to adopt CDS tools that improve outcomes and reduce costs.
Key players in the market
Some of the key players in Clinical Decision Support (CDS) for Chronic Care Market include Epic Systems Corporation, Cerner Corporation (Oracle Health), IBM Watson Health, Siemens Healthineers, Koninklijke Philips N.V., Wolters Kluwer Health, Allscripts Healthcare Solutions, McKesson Corporation, GE HealthCare, Agfa-Gevaert Group, Athenahealth, Inc., NextGen Healthcare, Inc., Elsevier Clinical Solutions, Medical Information Technology, Inc. (MEDITECH), Carestream Health, eClinicalWorks, Health Catalyst, and Zynx Health.
Key Developments:
In June 2025, Siemens Healthineers announced a theranostics research collaboration with a leading U.S. hospital to create a Therapy Command Center using advanced imaging (long-field-of-view PET/CT). The collaboration aims to accelerate theranostics research, optimize treatment pathways and provide clinicians integrated imaging+lab data to tailor therapies.
In June 2025, IBM unveiled watsonx AI Labs in New York City to co-create generative AI solutions with clients, startups and the local talent ecosystem. The initiative includes developer resources, partnerships (including acquisition activity to support the lab) to accelerate enterprise AI use cases in healthcare and other industries.
In April 2025, McKesson completed the acquisition of an 80% controlling interest in PRISM Vision Holdings (ophthalmology/retina services). McKesson said the transaction expands its specialty clinical services footprint and strengthens distribution/clinical reach in ophthalmology.
Components Covered:
• Software
• Services
• Other Components
Products Covered:
• Standalone CDS Systems
• Mobile-Based CDS Tools
• Integrated CDS with EHR
• AI-Driven CDS Platforms
• Other Products
Therapeutic Areas Covered:
• Cardiology
• Oncology
• Critical Care
• Infectious Diseases & Antimicrobial Stewardship
• Diabetes & Chronic Disease Management
• Medication Management
• Other Therapeutic Areas
Applications Covered:
• Clinical Guidelines
• Drug Allergy Alerts
• Drug-Drug Interactions
• Drug Dosing Support
• Clinical Reminders
• Therapeutic Planning
• Patient Monitoring
• Chronic Disease Management
• Diagnostic Support
• Other Applications
End Users Covered:
• Hospitals
• Clinics
• Ambulatory Surgical Centers
• Diagnostic & Imaging Centers
• Pharmaceutical & Biotechnology Companies
• Research Institutes
• Other End Users
Regions Covered:
• North America
o US
o Canada
o Mexico
• Europe
o Germany
o UK
o Italy
o France
o Spain
o Rest of Europe
• Asia Pacific
o Japan
o China
o India
o Australia
o New Zealand
o South Korea
o Rest of Asia Pacific
• South America
o Argentina
o Brazil
o Chile
o Rest of South America
• Middle East & Africa
o Saudi Arabia
o UAE
o Qatar
o South Africa
o Rest of Middle East & Africa
What our report offers:
- Market share assessments for the regional and country-level segments
- Strategic recommendations for the new entrants
- Covers Market data for the years 2024, 2025, 2026, 2028, and 2032
- Market Trends (Drivers, Constraints, Opportunities, Threats, Challenges, Investment Opportunities, and recommendations)
- Strategic recommendations in key business segments based on the market estimations
- Competitive landscaping mapping the key common trends
- Company profiling with detailed strategies, financials, and recent developments
- Supply chain trends mapping the latest technological advancements
Free Customization Offerings:
All the customers of this report will be entitled to receive one of the following free customization options:
• Company Profiling
o Comprehensive profiling of additional market players (up to 3)
o SWOT Analysis of key players (up to 3)
• Regional Segmentation
o Market estimations, Forecasts and CAGR of any prominent country as per the client's interest (Note: Depends on feasibility check)
• Competitive Benchmarking
o Benchmarking of key players based on product portfolio, geographical presence, and strategic alliances
Table of Contents
1 Executive Summary
2 Preface
2.1 Abstract
2.2 Stake Holders
2.3 Research Scope
2.4 Research Methodology
2.4.1 Data Mining
2.4.2 Data Analysis
2.4.3 Data Validation
2.4.4 Research Approach
2.5 Research Sources
2.5.1 Primary Research Sources
2.5.2 Secondary Research Sources
2.5.3 Assumptions
3 Market Trend Analysis
3.1 Introduction
3.2 Drivers
3.3 Restraints
3.4 Opportunities
3.5 Threats
3.6 Application Analysis
3.7 End User Analysis
3.8 Emerging Markets
3.9 Impact of Covid-19
4 Porters Five Force Analysis
4.1 Bargaining power of suppliers
4.2 Bargaining power of buyers
4.3 Threat of substitutes
4.4 Threat of new entrants
4.5 Competitive rivalry
5 Global Clinical Decision Support (CDS) for Chronic Care Market, By Component
5.1 Introduction
5.2 Software
5.2.1 EHR-integrated CDSS
5.2.2 Standalone CDSS
5.3 Services
5.3.1 Implementation & Training
5.3.2 Consulting
5.3.3 Support & Maintenance
5.4 Other Components
6 Global Clinical Decision Support (CDS) for Chronic Care Market, By Product
6.1 Introduction
6.2 Standalone CDS Systems
6.3 Mobile-Based CDS Tools
6.4 Integrated CDS with EHR
6.5 AI-Driven CDS Platforms
6.6 Other Products
7 Global Clinical Decision Support (CDS) for Chronic Care Market, By Therapeutic Area
7.1 Introduction
7.2 Cardiology
7.3 Oncology
7.4 Critical Care
7.5 Infectious Diseases & Antimicrobial Stewardship
7.6 Diabetes & Chronic Disease Management
7.7 Medication Management
7.8 Other Therapeutic Areas
8 Global Clinical Decision Support (CDS) for Chronic Care Market, By Application
8.1 Introduction
8.2 Clinical Guidelines
8.3 Drug Allergy Alerts
8.4 Drug-Drug Interactions
8.5 Drug Dosing Support
8.6 Clinical Reminders
8.7 Therapeutic Planning
8.8 Patient Monitoring
8.9 Chronic Disease Management
8.10 Diagnostic Support
8.11 Other Applications
9 Global Clinical Decision Support (CDS) for Chronic Care Market, By End User
9.1 Introduction
9.2 Hospitals
9.3 Clinics
9.4 Ambulatory Surgical Centers
9.5 Diagnostic & Imaging Centers
9.6 Pharmaceutical & Biotechnology Companies
9.7 Research Institutes
9.8 Other End Users
10 Global Clinical Decision Support (CDS) for Chronic Care Market, By Geography
10.1 Introduction
10.2 North America
10.2.1 US
10.2.2 Canada
10.2.3 Mexico
10.3 Europe
10.3.1 Germany
10.3.2 UK
10.3.3 Italy
10.3.4 France
10.3.5 Spain
10.3.6 Rest of Europe
10.4 Asia Pacific
10.4.1 Japan
10.4.2 China
10.4.3 India
10.4.4 Australia
10.4.5 New Zealand
10.4.6 South Korea
10.4.7 Rest of Asia Pacific
10.5 South America
10.5.1 Argentina
10.5.2 Brazil
10.5.3 Chile
10.5.4 Rest of South America
10.6 Middle East & Africa
10.6.1 Saudi Arabia
10.6.2 UAE
10.6.3 Qatar
10.6.4 South Africa
10.6.5 Rest of Middle East & Africa
11 Key Developments
11.1 Agreements, Partnerships, Collaborations and Joint Ventures
11.2 Acquisitions & Mergers
11.3 New Product Launch
11.4 Expansions
11.5 Other Key Strategies
12 Company Profiling
12.1 Epic Systems Corporation
12.2 Cerner Corporation (Oracle Health)
12.3 IBM Watson Health
12.4 Siemens Healthineers
12.5 Koninklijke Philips N.V.
12.6 Wolters Kluwer Health
12.7 Allscripts Healthcare Solutions
12.8 McKesson Corporation
12.9 GE HealthCare
12.10 Agfa-Gevaert Group
12.11 Athenahealth, Inc.
12.12 NextGen Healthcare, Inc.
12.13 Elsevier Clinical Solutions
12.14 Medical Information Technology, Inc. (MEDITECH)
12.15 Carestream Health
12.16 eClinicalWorks
12.17 Health Catalyst
12.18 Zynx Health
List of Tables
1 Global Clinical Decision Support (CDS) for Chronic Care Market Outlook, By Region (2024-2032) ($MN)
2 Global Clinical Decision Support (CDS) for Chronic Care Market Outlook, By Component (2024-2032) ($MN)
3 Global Clinical Decision Support (CDS) for Chronic Care Market Outlook, By Software (2024-2032) ($MN)
4 Global Clinical Decision Support (CDS) for Chronic Care Market Outlook, By EHR-integrated CDSS (2024-2032) ($MN)
5 Global Clinical Decision Support (CDS) for Chronic Care Market Outlook, By Standalone CDSS (2024-2032) ($MN)
6 Global Clinical Decision Support (CDS) for Chronic Care Market Outlook, By Services (2024-2032) ($MN)
7 Global Clinical Decision Support (CDS) for Chronic Care Market Outlook, By Implementation & Training (2024-2032) ($MN)
8 Global Clinical Decision Support (CDS) for Chronic Care Market Outlook, By Consulting (2024-2032) ($MN)
9 Global Clinical Decision Support (CDS) for Chronic Care Market Outlook, By Support & Maintenance (2024-2032) ($MN)
10 Global Clinical Decision Support (CDS) for Chronic Care Market Outlook, By Other Components (2024-2032) ($MN)
11 Global Clinical Decision Support (CDS) for Chronic Care Market Outlook, By Product (2024-2032) ($MN)
12 Global Clinical Decision Support (CDS) for Chronic Care Market Outlook, By Standalone CDS Systems (2024-2032) ($MN)
13 Global Clinical Decision Support (CDS) for Chronic Care Market Outlook, By Mobile-Based CDS Tools (2024-2032) ($MN)
14 Global Clinical Decision Support (CDS) for Chronic Care Market Outlook, By Integrated CDS with EHR (2024-2032) ($MN)
15 Global Clinical Decision Support (CDS) for Chronic Care Market Outlook, By AI-Driven CDS Platforms (2024-2032) ($MN)
16 Global Clinical Decision Support (CDS) for Chronic Care Market Outlook, By Other Products (2024-2032) ($MN)
17 Global Clinical Decision Support (CDS) for Chronic Care Market Outlook, By Therapeutic Area (2024-2032) ($MN)
18 Global Clinical Decision Support (CDS) for Chronic Care Market Outlook, By Cardiology (2024-2032) ($MN)
19 Global Clinical Decision Support (CDS) for Chronic Care Market Outlook, By Oncology (2024-2032) ($MN)
20 Global Clinical Decision Support (CDS) for Chronic Care Market Outlook, By Critical Care (2024-2032) ($MN)
21 Global Clinical Decision Support (CDS) for Chronic Care Market Outlook, By Infectious Diseases & Antimicrobial Stewardship (2024-2032) ($MN)
22 Global Clinical Decision Support (CDS) for Chronic Care Market Outlook, By Diabetes & Chronic Disease Management (2024-2032) ($MN)
23 Global Clinical Decision Support (CDS) for Chronic Care Market Outlook, By Medication Management (2024-2032) ($MN)
24 Global Clinical Decision Support (CDS) for Chronic Care Market Outlook, By Other Therapeutic Areas (2024-2032) ($MN)
25 Global Clinical Decision Support (CDS) for Chronic Care Market Outlook, By Application (2024-2032) ($MN)
26 Global Clinical Decision Support (CDS) for Chronic Care Market Outlook, By Clinical Guidelines (2024-2032) ($MN)
27 Global Clinical Decision Support (CDS) for Chronic Care Market Outlook, By Drug Allergy Alerts (2024-2032) ($MN)
28 Global Clinical Decision Support (CDS) for Chronic Care Market Outlook, By Drug-Drug Interactions (2024-2032) ($MN)
29 Global Clinical Decision Support (CDS) for Chronic Care Market Outlook, By Drug Dosing Support (2024-2032) ($MN)
30 Global Clinical Decision Support (CDS) for Chronic Care Market Outlook, By Clinical Reminders (2024-2032) ($MN)
31 Global Clinical Decision Support (CDS) for Chronic Care Market Outlook, By Therapeutic Planning (2024-2032) ($MN)
32 Global Clinical Decision Support (CDS) for Chronic Care Market Outlook, By Patient Monitoring (2024-2032) ($MN)
33 Global Clinical Decision Support (CDS) for Chronic Care Market Outlook, By Chronic Disease Management (2024-2032) ($MN)
34 Global Clinical Decision Support (CDS) for Chronic Care Market Outlook, By Diagnostic Support (2024-2032) ($MN)
35 Global Clinical Decision Support (CDS) for Chronic Care Market Outlook, By Other Applications (2024-2032) ($MN)
36 Global Clinical Decision Support (CDS) for Chronic Care Market Outlook, By End User (2024-2032) ($MN)
37 Global Clinical Decision Support (CDS) for Chronic Care Market Outlook, By Hospitals (2024-2032) ($MN)
38 Global Clinical Decision Support (CDS) for Chronic Care Market Outlook, By Clinics (2024-2032) ($MN)
39 Global Clinical Decision Support (CDS) for Chronic Care Market Outlook, By Ambulatory Surgical Centers (2024-2032) ($MN)
40 Global Clinical Decision Support (CDS) for Chronic Care Market Outlook, By Diagnostic & Imaging Centers (2024-2032) ($MN)
41 Global Clinical Decision Support (CDS) for Chronic Care Market Outlook, By Pharmaceutical & Biotechnology Companies (2024-2032) ($MN)
42 Global Clinical Decision Support (CDS) for Chronic Care Market Outlook, By Research Institutes (2024-2032) ($MN)
43 Global Clinical Decision Support (CDS) for Chronic Care Market Outlook, By Other End Users (2024-2032) ($MN)
Note: Tables for North America, Europe, APAC, South America, and Middle East & Africa Regions are also represented in the same manner as above.
List of Figures
RESEARCH METHODOLOGY
We at ‘Stratistics’ opt for an extensive research approach which involves data mining, data validation, and data analysis. The various research sources include in-house repository, secondary research, competitor’s sources, social media research, client internal data, and primary research.
Our team of analysts prefers the most reliable and authenticated data sources in order to perform the comprehensive literature search. With access to most of the authenticated data bases our team highly considers the best mix of information through various sources to obtain extensive and accurate analysis.
Each report takes an average time of a month and a team of 4 industry analysts. The time may vary depending on the scope and data availability of the desired market report. The various parameters used in the market assessment are standardized in order to enhance the data accuracy.
Data Mining
The data is collected from several authenticated, reliable, paid and unpaid sources and is filtered depending on the scope & objective of the research. Our reports repository acts as an added advantage in this procedure. Data gathering from the raw material suppliers, distributors and the manufacturers is performed on a regular basis, this helps in the comprehensive understanding of the products value chain. Apart from the above mentioned sources the data is also collected from the industry consultants to ensure the objective of the study is in the right direction.
Market trends such as technological advancements, regulatory affairs, market dynamics (Drivers, Restraints, Opportunities and Challenges) are obtained from scientific journals, market related national & international associations and organizations.
Data Analysis
From the data that is collected depending on the scope & objective of the research the data is subjected for the analysis. The critical steps that we follow for the data analysis include:
- Product Lifecycle Analysis
- Competitor analysis
- Risk analysis
- Porters Analysis
- PESTEL Analysis
- SWOT Analysis
The data engineering is performed by the core industry experts considering both the Marketing Mix Modeling and the Demand Forecasting. The marketing mix modeling makes use of multiple-regression techniques to predict the optimal mix of marketing variables. Regression factor is based on a number of variables and how they relate to an outcome such as sales or profits.
Data Validation
The data validation is performed by the exhaustive primary research from the expert interviews. This includes telephonic interviews, focus groups, face to face interviews, and questionnaires to validate our research from all aspects. The industry experts we approach come from the leading firms, involved in the supply chain ranging from the suppliers, distributors to the manufacturers and consumers so as to ensure an unbiased analysis.
We are in touch with more than 15,000 industry experts with the right mix of consultants, CEO's, presidents, vice presidents, managers, experts from both supply side and demand side, executives and so on.
The data validation involves the primary research from the industry experts belonging to:
- Leading Companies
- Suppliers & Distributors
- Manufacturers
- Consumers
- Industry/Strategic Consultants
Apart from the data validation the primary research also helps in performing the fill gap research, i.e. providing solutions for the unmet needs of the research which helps in enhancing the reports quality.
For more details about research methodology, kindly write to us at info@strategymrc.com
Frequently Asked Questions
In case of any queries regarding this report, you can contact the customer service by filing the “Inquiry Before Buy” form available on the right hand side. You may also contact us through email: info@strategymrc.com or phone: +1-301-202-5929
Yes, the samples are available for all the published reports. You can request them by filling the “Request Sample” option available in this page.
Yes, you can request a sample with your specific requirements. All the customized samples will be provided as per the requirement with the real data masked.
All our reports are available in Digital PDF format. In case if you require them in any other formats, such as PPT, Excel etc you can submit a request through “Inquiry Before Buy” form available on the right hand side. You may also contact us through email: info@strategymrc.com or phone: +1-301-202-5929
We offer a free 15% customization with every purchase. This requirement can be fulfilled for both pre and post sale. You may send your customization requirements through email at info@strategymrc.com or call us on +1-301-202-5929.
We have 3 different licensing options available in electronic format.
- Single User Licence: Allows one person, typically the buyer, to have access to the ordered product. The ordered product cannot be distributed to anyone else.
- 2-5 User Licence: Allows the ordered product to be shared among a maximum of 5 people within your organisation.
- Corporate License: Allows the product to be shared among all employees of your organisation regardless of their geographical location.
All our reports are typically be emailed to you as an attachment.
To order any available report you need to register on our website. The payment can be made either through CCAvenue or PayPal payments gateways which accept all international cards.
We extend our support to 6 months post sale. A post sale customization is also provided to cover your unmet needs in the report.
Request Customization
We offer complimentary customization of up to 15% with every purchase. To share your customization requirements, feel free to email us at info@strategymrc.com or call us on +1-301-202-5929. .
Please Note: Customization within the 15% threshold is entirely free of charge. If your request exceeds this limit, we will conduct a feasibility assessment. Following that, a detailed quote and timeline will be provided.
WHY CHOOSE US ?
Assured Quality
Best in class reports with high standard of research integrity
24X7 Research Support
Continuous support to ensure the best customer experience.
Free Customization
Adding more values to your product of interest.
Safe & Secure Access
Providing a secured environment for all online transactions.
Trusted by 600+ Brands
Serving the most reputed brands across the world.
